Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Duodenum | 1 | 2024 | 42 | 0.890 |
Why?
|
| Abdominal Injuries | 1 | 2024 | 30 | 0.880 |
Why?
|
| Tissue Engineering | 6 | 2017 | 141 | 0.830 |
Why?
|
| Crisis Intervention | 1 | 2021 | 27 | 0.710 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2017 | 225 | 0.670 |
Why?
|
| Thoracostomy | 1 | 2020 | 8 | 0.650 |
Why?
|
| Pleurodesis | 1 | 2020 | 9 | 0.650 |
Why?
|
| Pneumothorax | 1 | 2020 | 50 | 0.630 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 61 | 0.620 |
Why?
|
| Inpatients | 1 | 2021 | 305 | 0.590 |
Why?
|
| Child | 17 | 2025 | 4526 | 0.590 |
Why?
|
| Hospitalization | 9 | 2024 | 1364 | 0.540 |
Why?
|
| Adolescent | 14 | 2025 | 6245 | 0.490 |
Why?
|
| Venous Thromboembolism | 3 | 2023 | 149 | 0.470 |
Why?
|
| Bariatric Surgery | 2 | 2025 | 61 | 0.440 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 2576 | 0.430 |
Why?
|
| Pediatric Obesity | 2 | 2025 | 109 | 0.410 |
Why?
|
| Blood Vessels | 1 | 2012 | 62 | 0.370 |
Why?
|
| Craniocerebral Trauma | 3 | 2020 | 56 | 0.340 |
Why?
|
| Infant | 7 | 2024 | 1645 | 0.330 |
Why?
|
| Wounds and Injuries | 2 | 2023 | 246 | 0.310 |
Why?
|
| Skiing | 2 | 2020 | 11 | 0.310 |
Why?
|
| Specialties, Surgical | 2 | 2020 | 48 | 0.300 |
Why?
|
| Tissue Scaffolds | 6 | 2017 | 84 | 0.290 |
Why?
|
| Crohn Disease | 2 | 2020 | 110 | 0.290 |
Why?
|
| Athletic Injuries | 2 | 2020 | 83 | 0.290 |
Why?
|
| Firearms | 2 | 2019 | 70 | 0.290 |
Why?
|
| Female | 21 | 2025 | 32880 | 0.280 |
Why?
|
| Male | 18 | 2025 | 29891 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2024 | 873 | 0.270 |
Why?
|
| Child, Preschool | 5 | 2024 | 1990 | 0.260 |
Why?
|
| Injury Severity Score | 2 | 2024 | 107 | 0.250 |
Why?
|
| United States | 10 | 2025 | 7843 | 0.250 |
Why?
|
| Models, Animal | 3 | 2017 | 235 | 0.250 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6658 | 0.240 |
Why?
|
| Humans | 27 | 2025 | 63445 | 0.240 |
Why?
|
| Portal Vein | 2 | 2017 | 38 | 0.240 |
Why?
|
| Length of Stay | 3 | 2024 | 812 | 0.230 |
Why?
|
| Cultural Diversity | 1 | 2025 | 53 | 0.220 |
Why?
|
| Accidents, Traffic | 1 | 2024 | 146 | 0.210 |
Why?
|
| Career Choice | 1 | 2025 | 132 | 0.200 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 98 | 0.200 |
Why?
|
| Minority Groups | 1 | 2025 | 139 | 0.200 |
Why?
|
| Comorbidity | 3 | 2020 | 1120 | 0.190 |
Why?
|
| Wounds, Gunshot | 2 | 2019 | 56 | 0.190 |
Why?
|
| General Surgery | 1 | 2025 | 211 | 0.190 |
Why?
|
| Head Protective Devices | 2 | 2020 | 19 | 0.180 |
Why?
|
| Tertiary Healthcare | 1 | 2021 | 15 | 0.180 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 360 | 0.180 |
Why?
|
| Snow Sports | 1 | 2020 | 3 | 0.170 |
Why?
|
| Surgeons | 2 | 2020 | 183 | 0.170 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 9 | 0.170 |
Why?
|
| Young Adult | 5 | 2025 | 4694 | 0.160 |
Why?
|
| Infant Mortality | 1 | 2020 | 20 | 0.160 |
Why?
|
| Sex Factors | 2 | 2020 | 978 | 0.160 |
Why?
|
| Chest Tubes | 1 | 2020 | 17 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 14 | 0.160 |
Why?
|
| Deficiency Diseases | 1 | 2019 | 13 | 0.160 |
Why?
|
| Play and Playthings | 1 | 2019 | 20 | 0.160 |
Why?
|
| Bites and Stings | 1 | 2019 | 11 | 0.160 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2019 | 18 | 0.150 |
Why?
|
| Accidental Falls | 1 | 2020 | 127 | 0.150 |
Why?
|
| Age Factors | 2 | 2021 | 1558 | 0.150 |
Why?
|
| Social Class | 1 | 2020 | 133 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2021 | 360 | 0.150 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 47 | 0.150 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 3 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2020 | 1358 | 0.150 |
Why?
|
| Dogs | 1 | 2019 | 325 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 422 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 81 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 102 | 0.140 |
Why?
|
| Suicide | 1 | 2019 | 134 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 183 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 550 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 266 | 0.120 |
Why?
|
| Risk Factors | 6 | 2023 | 5354 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 691 | 0.120 |
Why?
|
| Dioxoles | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 28 | 0.120 |
Why?
|
| Nanofibers | 1 | 2015 | 18 | 0.110 |
Why?
|
| Benzamides | 1 | 2015 | 65 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 129 | 0.110 |
Why?
|
| Neurons | 3 | 2004 | 922 | 0.110 |
Why?
|
| Receptors, Nicotinic | 2 | 2004 | 67 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 480 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2015 | 135 | 0.110 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Hippocampus | 2 | 2004 | 270 | 0.100 |
Why?
|
| Animals | 11 | 2019 | 20663 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 87 | 0.090 |
Why?
|
| Nanomedicine | 1 | 2012 | 24 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 115 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 169 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 190 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 238 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 150 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2018 | 808 | 0.080 |
Why?
|
| ROC Curve | 2 | 2021 | 282 | 0.080 |
Why?
|
| Infant, Premature | 2 | 2020 | 184 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 937 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 888 | 0.060 |
Why?
|
| Mice | 7 | 2017 | 10844 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 1276 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2004 | 7 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2004 | 19 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Olfactory Bulb | 1 | 2004 | 19 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2025 | 199 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 187 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 835 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2004 | 230 | 0.050 |
Why?
|
| Stem Cells | 1 | 2004 | 259 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 123 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 424 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 46 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 676 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1008 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 58 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 867 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2004 | 988 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 21 | 0.040 |
Why?
|
| North America | 1 | 2020 | 111 | 0.040 |
Why?
|
| Ligation | 1 | 2020 | 39 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 165 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 60 | 0.040 |
Why?
|
| Contusions | 1 | 2019 | 11 | 0.040 |
Why?
|
| Torso | 1 | 2019 | 19 | 0.040 |
Why?
|
| Neonatologists | 1 | 2019 | 1 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 198 | 0.040 |
Why?
|
| Eye Injuries | 1 | 2019 | 14 | 0.040 |
Why?
|
| Neck Injuries | 1 | 2019 | 20 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2020 | 53 | 0.040 |
Why?
|
| Income | 1 | 2020 | 169 | 0.040 |
Why?
|
| Laparotomy | 1 | 2019 | 52 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 108 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1377 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 126 | 0.040 |
Why?
|
| X-Rays | 1 | 2018 | 46 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 495 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 16824 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 373 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 418 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 107 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1094 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 193 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 287 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 406 | 0.040 |
Why?
|
| Leadership | 1 | 2020 | 206 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 189 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 25 | 0.040 |
Why?
|
| Rural Population | 1 | 2019 | 203 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3396 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 484 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 519 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 1644 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 877 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2015 | 5 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2015 | 18 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 396 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 73 | 0.030 |
Why?
|
| Polyesters | 1 | 2015 | 47 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2015 | 76 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 179 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 104 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2079 | 0.030 |
Why?
|
| Aorta | 1 | 2015 | 114 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 139 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 175 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 712 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 583 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 956 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 173 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2681 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 2075 | 0.020 |
Why?
|
| Polymers | 1 | 2015 | 325 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 62 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2004 | 2109 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1039 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5680 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2458 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3768 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 318 | 0.020 |
Why?
|
| Helplessness, Learned | 1 | 2004 | 2 | 0.010 |
Why?
|
| Nortriptyline | 1 | 2004 | 3 | 0.010 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 3 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 28 | 0.010 |
Why?
|
| Mecamylamine | 1 | 2004 | 14 | 0.010 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 19 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 43 | 0.010 |
Why?
|
| Swimming | 1 | 2004 | 27 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 13 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 132 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 46 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 127 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 608 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 450 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 864 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 896 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1277 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 688 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1079 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 745 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1617 | 0.010 |
Why?
|